Get Premium Data for Cyber Monday: Up to 55% Off InvestingProCLAIM SALE

Moderna Inc (M1RN34)

B3
Currency in BRL
13.05
+0.33(+2.59%)
Delayed Data

M1RN34 Income Statement

Advanced Income Statement
Period Ending:
2016
31/12
2017
31/12
2018
31/12
2019
31/12
2020
31/12
2021
31/12
2022
31/12
2023
31/12
Total Revenues
aa.aaaa.aaaa.aaaa.aaaa.aa18,47119,2636,848
Total Revenues Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+2,200.25%+4.29%-64.45%
Cost Of Revenues
aa.aaaa.aaaa.aaaa.aaaa.aa4,6088,7119,538
Gross Profit
aa.aaaa.aaaa.aaaa.aaaa.aa13,86310,552-2,690
Gross Profit Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+2,510.96%-23.88%-125.49%
Gross Profit Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa75.05%54.78%-39.28%
Other Operating Expenses, Total
aa.aaaa.aaaa.aaaa.aaaa.aa5671,1321,549
Other Operating Expenses, Total Growth
R&D Expenses
Selling General & Admin Expenses
Other Operating Expenses
Operating Income
aa.aaaa.aaaa.aaaa.aaaa.aa13,2969,420-4,239
Operating Income Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+1,842.6%-29.15%-145%
EBIT Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa71.98%48.9%-61.9%
Net Interest Expenses
aa.aaaa.aaaa.aaaa.aaaa.aa1171383
Net Interest Expenses Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-93.33%+17,000%+123.98%
Interest Expense, Total
aa.aaaa.aaaa.aaaa.aaaa.aa-17-29-38
Interest And Investment Income
aa.aaaa.aaaa.aaaa.aaaa.aa18200421
Other Non Operating Expenses, Total
aa.aaaa.aaaa.aaaa.aaaa.aa-124-14
EBT, Excl. Unusual Items
aa.aaaa.aaaa.aaaa.aaaa.aa13,2859,595-3,870
Gain (Loss) On Sale Of Assets
aa.aaaa.aaaa.aaaa.aaaa.aa---
Other Unusual Items, Total
aa.aaaa.aaaa.aaaa.aaaa.aa---
EBT, Incl. Unusual Items
aa.aaaa.aaaa.aaaa.aaaa.aa13,2859,575-3,942
EBT, Incl. Unusual Items Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+1,885.62%-27.93%-141.17%
EBT, Incl. Unusual Items Margin
aa.aaaa.aaaa.aaaa.aaaa.aa71.92%49.71%-57.56%
Income Tax Expense
aa.aaaa.aaaa.aaaa.aaaa.aa1,0831,213772
Net Income to Company
aa.aaaa.aaaa.aaaa.aaaa.aa12,2028,362-4,714
Minority Interest
aa.aaaa.aaaa.aaaa.aaaa.aa---
Net Income
aa.aaaa.aaaa.aaaa.aaaa.aa12,2028,362-4,714
Net Income Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+1,733.47%-31.47%-156.37%
Net Income Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa66.06%43.41%-68.84%
Preferred Dividend and Other Adjustments
aa.aaaa.aaaa.aaaa.aaaa.aa---
Net Income to Common Excl. Extra Items
aa.aaaa.aaaa.aaaa.aaaa.aa12,2028,362-4,714
Basic EPS - Continuing Operations
aa.aaaa.aaaa.aaaa.aaaa.aa30.2821.22-12.34
Basic EPS - Continuing Operations Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+1,644.3%-29.9%-158.14%
Diluted EPS - Continuing Operations
aa.aaaa.aaaa.aaaa.aaaa.aa28.2920.12-12.34
Diluted EPS - Continuing Operations Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+1,542.9%-28.88%-161.33%
Basic Weighted Average Shares Outstanding
aa.aaaa.aaaa.aaaa.aaaa.aa403394382
Diluted Weighted Average Shares Outstanding
aa.aaaa.aaaa.aaaa.aaaa.aa431416382
Dividend Per Share
aa.aaaa.aaaa.aaaa.aaaa.aa---
Dividend Per Share Growth
aa.aaaa.aaaa.aaaa.aaaa.aa---
EBITDA
aa.aaaa.aaaa.aaaa.aaaa.aa13,5289,768-3,618
EBITDA Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+1,948.09%-27.79%-137.04%
EBITDA Margin %
aa.aaaa.aa